Syra Health Corp. Class A Common Stock (SYRA)

USD 0.38

(-3.8%)

Operating Income Summary of Syra Health Corp. Class A Common Stock

  • Syra Health Corp. Class A Common Stock's latest annual operating income in 2023 was -2.88 Million USD , down -38.18% from previous year.
  • Syra Health Corp. Class A Common Stock's latest quarterly operating income in 2024 Q3 was -428.91 Thousand USD , up 69.15% from previous quarter.
  • Syra Health Corp. Class A Common Stock reported an annual operating income of -2.08 Million USD in 2022, down -63610.21% from previous year.
  • Syra Health Corp. Class A Common Stock reported an annual operating income of -3280.00 USD in 2021, up 23.19% from previous year.
  • Syra Health Corp. Class A Common Stock reported a quarterly operating income of -428.91 Thousand USD for 2024 Q3, up 69.15% from previous quarter.
  • Syra Health Corp. Class A Common Stock reported a quarterly operating income of -1.44 Million USD for 2024 Q1, down -46.42% from previous quarter.

Annual Operating Income Chart of Syra Health Corp. Class A Common Stock (2023 - 2020)

Historical Annual Operating Income of Syra Health Corp. Class A Common Stock (2023 - 2020)

Year Operating Income Operating Income Growth
2023 -2.88 Million USD -38.18%
2022 -2.08 Million USD -63610.21%
2021 -3280.00 USD 23.19%
2020 -4270.00 USD 0.0%

Peer Operating Income Comparison of Syra Health Corp. Class A Common Stock

Name Operating Income Operating Income Difference
Acadia Healthcare Company, Inc. 506.59 Million USD 100.57%
Addus HomeCare Corporation 90.95 Million USD 103.175%
AirSculpt Technologies, Inc. 9.48 Million USD 130.45%
Amedisys, Inc. 156.39 Million USD 101.846%
American Oncology Network, Inc. -49.15 Million USD 94.125%
Astrana Health, Inc. 84.61 Million USD 103.413%
Aveanna Healthcare Holdings Inc. 8.07 Million USD 135.773%
IMAC Holdings, Inc. -6.37 Million USD 54.708%
biote Corp. 28.65 Million USD 110.076%
Cryo-Cell International, Inc. -12.3 Million USD 76.531%
Cross Country Healthcare, Inc. 112.71 Million USD 102.562%
COMPASS Pathways plc -136.91 Million USD 97.891%
DocGo Inc. 15.05 Million USD 119.18%
The Ensign Group, Inc. 255.36 Million USD 101.131%
Healthcare Services Group, Inc. 62.35 Million USD 104.631%
InnovAge Holding Corp. -23.18 Million USD 87.543%
Assure Holdings Corp. -20.08 Million USD 85.621%
The Joint Corp. -2.07 Million USD -39.29%
LifeStance Health Group, Inc. -189.13 Million USD 98.473%
Mobile-health Network Solutions Class A Ordinary Shares -15.7 Million USD 81.612%
ModivCare Inc. -139.94 Million USD 97.937%
NewGenIvf Group Limited 42.24 Thousand USD 6935.848%
Novo Integrated Sciences, Inc. -8.55 Million USD 66.239%
Option Care Health, Inc. 314.59 Million USD 100.918%
P3 Health Partners Inc. -167.86 Million USD 98.28%
P3 Health Partners Inc. -167.86 Million USD 98.28%
The Pennant Group, Inc. 25.16 Million USD 111.473%
Surgery Partners, Inc. 328 Million USD 100.88%
Talkspace, Inc. -23.2 Million USD 87.558%
Talkspace, Inc. -23.2 Million USD 87.558%
The Oncology Institute, Inc. -77.01 Million USD 96.251%
The Oncology Institute, Inc. -77.01 Million USD 96.251%